World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
154
Citations
125627
World Ranking
130
National Ranking
77

Medicine

D-Index
155
Citations
129645
World Ranking
932
National Ranking
531

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • 2000 - Member of the National Academy of Medicine (NAM)
  • 1995 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Clara D. Bloomfield was affiliated with The Ohio State University in the United States. Their research primarily focused on the field of medicine with a significant emphasis on hematology. The scientist contributed extensively to areas such as acute myeloid leukemia research, acute lymphoblastic leukemia research, and investigations related to myeloproliferative neoplasms.

The main fields of study covered in their work included Medicine and Biochemistry, Genetics, and Molecular Biology. Subfields of study spanned hematology, molecular biology, public health, environmental and occupational health, cancer research, and genetics.

Bloomfield authored and co-authored research papers published in scientific journals and venues including:

  • Leukemia
  • Blood
  • Blood Advances
  • UNC Libraries
  • Proceedings of the National Academy of Sciences

Their recent publications included:

  • Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin, 2021, Blood
  • Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ KMT2A, 2020, Proceedings of the National Academy of Sciences
  • Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years, 2020, Leukemia
  • Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial, 2021, Leukemia
  • Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results, 2021, Leukemia

Frequently collaborating co-authors included Jessica Kohlschmidt, Richard M. Stone, Krzysztof Mrózek, John C. Byrd, and Deedra Nicolet.

Themes addressed in Bloomfield's work also covered cancer genomics and diagnostics, histone deacetylase inhibitors research, and cancer-related molecular mechanisms research.

During the course of their career, Clara D. Bloomfield received recognition through memberships and fellowships such as:

  • Member of the National Academy of Medicine (NAM), 2000
  • Fellow of the American Association for the Advancement of Science (AAAS), 1995
  • Member of the Association of American Physicians

Best Publications

  • Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

    T. R. Golub;T. R. Golub;D. K. Slonim;P. Tamayo;C. Huard

  • The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

    Daniel A. Arber;Attilio Orazi;Robert Hasserjian;Jürgen Thiele

  • The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

    James W. Vardiman;Jüergen Thiele;Daniel A. Arber;Richard D. Brunning

  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

  • World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

    Nancy Lee Harris;Elaine S. Jaffe;Jacques Diebold;Georges Flandrin

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

    John C. Byrd;Krzysztof Mrózek;Richard K. Dodge;Andrew J. Carroll

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Richard M. Stone;Sumithra J. Mandrekar;Ben L. Sanford;Kristina Laumann

  • Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

    Joseph F. Costello;Joseph F. Costello;Michael C. Frühwald;Michael C. Frühwald;Dominic J. Smiraglia;Laura J. Rush

  • Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

    K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey

  • All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

    Martin S. Tallman;Janet W. Andersen;Charles A. Schiffer;Frederick R. Appelbaum

  • The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997

    N. L. Harris;E. S. Jaffe;J. Diebold;G. Flandrin

  • MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

    Ramiro Garzon;Shujun Liu;Muller Fabbri;Zhongfa Liu

  • Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

    B D Cheson;P A Cassileth;D R Head;C A Schiffer

  • IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

    Guido Marcucci;Kati Maharry;Yue-Zhong Wu;Michael D. Radmacher

  • Cytogenetics in acute leukemia

    Krzysztof Mrózek;Nyla A Heerema;Clara D Bloomfield

  • Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

    Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka

  • Absence of the Wild-Type Allele Predicts Poor Prognosis in Adult de Novo Acute Myeloid Leukemia with Normal Cytogenetics and the Internal Tandem Duplication of FLT3 A Cancer and Leukemia Group B Study

    Susan P. Whitman;Kellie J. Archer;Lan Feng;Claudia Baldus

  • Frequency of Prolonged Remission Duration after High-Dose Cytarabine Intensification in Acute Myeloid Leukemia Varies by Cytogenetic Subtype

    Clara D. Bloomfield;David Lawrence;John C. Byrd;Andrew Carroll

  • Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study

    Peter Paschka;Guido Marcucci;Amy S. Ruppert;Krzysztof Mrózek

Frequent Co-Authors

Krzysztof Mrózek
Krzysztof Mrózek The Ohio State University
Guido Marcucci
Guido Marcucci City Of Hope National Medical Center
Richard A. Larson
Richard A. Larson University of Chicago
Bayard L. Powell
Bayard L. Powell Wake Forest University
Michael A. Caligiuri
Michael A. Caligiuri City Of Hope National Medical Center
Richard Stone
Richard Stone Harvard University
Andrew J. Carroll
Andrew J. Carroll University of Alabama at Birmingham
Jonathan E. Kolitz
Jonathan E. Kolitz Hofstra University
John C. Byrd
John C. Byrd University of Pittsburgh Cancer Institute
Susan P. Whitman
Susan P. Whitman The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As the healthcare landscape evolves, online degrees have become a practical option for those seeking flexibility and career advancement in the medical field. For nursing professionals aiming for leadership or advanced clinical roles, the 1 year dnp program online offers a fast-track to a Doctor of Nursing Practice degree, allowing graduates to enter high-level positions in less time.

Budget-conscious students can explore affordable dnp programs without sacrificing quality, making advanced degrees more accessible. Meanwhile, those starting their nursing journey may consider online lpn programs that deliver essential skills for practical nursing roles through flexible, accelerated coursework.

Specializations are also in high demand. The mental health sector, for example, offers unique opportunities through psych np programs, preparing nurses to provide psychiatric care and address ongoing behavioral health needs. These online pathways enable students to balance their studies with work or family commitments while opening doors to diverse and rewarding healthcare careers.

Best Scientists Citing Clara D. Bloomfield

Recently Published Articles